Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 93 | $20,509,998 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 213 | 242.37 | 51,625 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 235 | 243.36 | 57,190 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 158 | 244.41 | 38,617 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 116 | 245.26 | 28,450 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 48 | 246.18 | 11,817 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 5 | 247.35 | 1,237 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 1 | 248.36 | 248 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 583 | 243.13 | 141,745 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 273 | 244.43 | 66,729 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 117 | 245.53 | 28,727 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 147 | 239.25 | 35,170 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 343 | 240.92 | 82,636 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 198 | 241.6 | 47,837 | D |
05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 120 | 242.7 | 29,124 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 51 | 236.51 | 12,062 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 40 | 238.33 | 9,533 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 41 | 239.18 | 9,806 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 91 | 240.32 | 21,869 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 149 | 241.51 | 35,985 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 352 | 242.44 | 85,339 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 142 | 243.23 | 34,539 | D |
03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 69 | 244.11 | 16,844 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 349 | 252.5 | 88,122 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 386 | 253.37 | 97,801 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 258 | 254.35 | 65,622 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 110 | 255.56 | 28,112 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 126 | 256.29 | 32,293 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 60 | 257.51 | 15,451 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 77 | 258.07 | 19,871 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 27 | 259.72 | 7,012 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 49 | 260.57 | 12,768 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 60 | 261.45 | 15,687 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 27 | 263.33 | 7,110 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 14 Feb 2025 | Sale | 32 | 264.87 | 8,476 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 18 Feb 2025 | Sale | 862 | 250.11 | 215,595 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 18 Feb 2025 | Sale | 306 | 250.73 | 76,723 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 18 Feb 2025 | Sale | 110 | 251.6 | 27,676 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 18 Feb 2025 | Sale | 83 | 256.05 | 21,252 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 18 Feb 2025 | Sale | 107 | 257.99 | 27,605 | D |
18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 18 Feb 2025 | Sale | 80 | 259.1 | 20,728 | D |
29 Jan 2025 16:03 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Jan 2025 | Sale | 52,592 | 285 | 14,988,720 | D |
13 Dec 2024 16:13 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 12 Dec 2024 | Sale | 121 | 247.48 | 29,945 | D |
13 Dec 2024 16:13 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 12 Dec 2024 | Sale | 186 | 248.99 | 46,312 | D |
13 Dec 2024 16:13 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 12 Dec 2024 | Sale | 426 | 250.08 | 106,534 | D |
13 Dec 2024 16:13 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 12 Dec 2024 | Sale | 778 | 251.68 | 195,807 | D |
13 Dec 2024 16:13 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 12 Dec 2024 | Sale | 100 | 252.94 | 25,294 | D |
13 Dec 2024 16:13 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 12 Dec 2024 | Sale | 140 | 254.37 | 35,612 | D |
13 Dec 2024 16:13 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 12 Dec 2024 | Sale | 1 | 255.8 | 256 | D |
27 Nov 2024 17:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 26 Nov 2024 | Sale | 30 | 247.77 | 7,433 | D |
27 Nov 2024 17:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 26 Nov 2024 | Sale | 246 | 249.6 | 61,402 | D |
27 Nov 2024 17:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 26 Nov 2024 | Sale | 364 | 250.68 | 91,248 | D |
27 Nov 2024 17:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 26 Nov 2024 | Sale | 945 | 251.42 | 237,592 | D |
27 Nov 2024 17:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 26 Nov 2024 | Sale | 97 | 252.27 | 24,470 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 219 | 235.19 | 51,507 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 242 | 234.66 | 56,788 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 151 | 233.53 | 35,263 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 283 | 232.54 | 65,809 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 129 | 231.59 | 29,875 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 398 | 229.93 | 91,512 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 348 | 229.06 | 79,713 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 169 | 228.3 | 38,583 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 45 | 226.82 | 10,207 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 24 | 225.55 | 5,413 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 17 | 224.17 | 3,811 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 78 | 221.71 | 17,293 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 115 | 156.38 | 17,984 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 17 | 157.3 | 2,674 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 194 | 155.45 | 30,157 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 247 | 154.54 | 38,171 | D |
20 Feb 2024 16:09 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 16 Feb 2024 | Sale | 672 | 148.24 | 99,617 | D |
20 Feb 2024 16:09 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 16 Feb 2024 | Sale | 156 | 149.03 | 23,249 | D |
20 Feb 2024 16:09 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 16 Feb 2024 | Sale | 480 | 147.5 | 70,800 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 07 Aug 2023 | Sale | 240 | 185.32 | 44,477 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 07 Aug 2023 | Sale | 814 | 184.65 | 150,305 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 07 Aug 2023 | Sale | 3,112 | 183.58 | 571,301 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 164 | 189.31 | 31,047 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 15 | 188.4 | 2,826 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 86 | 187.37 | 16,114 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 945 | 186.39 | 176,139 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 658 | 184.7 | 121,533 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 1,593 | 185.54 | 295,565 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 93 | 201.3 | 18,721 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 955 | 200.35 | 191,334 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 385 | 199.54 | 76,823 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 715 | 198.03 | 141,591 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 103 | 196.62 | 20,252 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 204 | 195.46 | 39,874 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 129 | 197.08 | 25,423 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 80 | 195.65 | 15,652 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 779 | 194.94 | 151,858 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 700 | 193.93 | 135,751 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 151 | 193.18 | 29,170 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)